Energy News / Shareholders Foundation, Inc.

NASDAQ: STAA Shareholder Alert: Investigation Concerning Potential Wrongdoing at STAAR Surgical Company

Via: ReleaseWire

Updated 2:21 PM CDT, Fri, May 24,2019

An investigation on behalf of investors in STAAR Surgical Company (NASDAQ: STAA) shares over potential wrongdoing at STAAR Surgical Company was announced and NASDAQ: STAA stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 05/24/2019 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at STAAR Surgical Company.

Investors who purchased shares of STAAR Surgical Company (NASDAQ: STAA) and currently hold any of those NASDAQ: STAA shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain STAAR Surgical Company (NASDAQ: STAA officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

STAAR Surgical Company reported that its annual Total Revenue rose from $90.61 million in 2017 to $123.95 million in 2018 and that its Net Loss of $2.13 million in 2017 turned into a Net Income of $4.96 million in 2018.

On May 3, 2019 , STAAR disclosed receipt of a letter from the Center for Devices and Radiological Health of the U.S. Food and Drug Administration ("FDA") regarding its review of the Company's premarket approval application ("PMA") supplement regarding EVO/EVO+ Visian Implantable Collamer Lens for Myopia and EVO/EVO+ Visian Toric Implantable Collamer Lens for Myopia with Astigmatism. In the letter, the FDA specifically "advised the Company that its PMA supplement lacked information, particularly the clinical evidence and analysis, that would permit the completion of the review and determination of whether there is a reasonable assurance of the device's safety and effectiveness for its intended use."

Shares of STAAR Surgical Company (NASDAQ: STAA) declined to $21.70 per share on May 1, 2019.

Those who purchased shares of STAAR Surgical Company (NASDAQ: STAA), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaq-staa-shareholder-alert-investigation-concerning-potential-wrongdoing-at-staar-surgical-company-1224173.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com